Cocrystal Pharma Files 8-K with Corporate Updates

Ticker: COCP · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1412486

Cocrystal Pharma, INC. 8-K Filing Summary
FieldDetail
CompanyCocrystal Pharma, INC. (COCP)
Form Type8-K
Filed DateApr 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-disclosure, filing-update

Related Tickers: COCP

TL;DR

Cocrystal Pharma (COCP) filed an 8-K on 4/24/25 updating corporate info and former names.

AI Summary

Cocrystal Pharma, Inc. filed an 8-K on April 24, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 19805 N. Creek Parkway, Bothell, WA 98011, with a business phone number of (876) 459-1831. The company was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.

Why It Matters

This filing provides essential corporate information and disclosures, which are important for investors to stay informed about the company's official status and reporting.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a Current Report for Cocrystal Pharma, Inc., covering Regulation FD Disclosure and Financial Statements and Exhibits, with the earliest event reported on April 24, 2025.

Where are Cocrystal Pharma, Inc.'s principal executive offices located?

The principal executive offices of Cocrystal Pharma, Inc. are located at 19805 N. Creek Parkway, Bothell, WA 98011.

What is the business phone number for Cocrystal Pharma, Inc.?

The business phone number for Cocrystal Pharma, Inc. is (876) 459-1831.

What were some of Cocrystal Pharma, Inc.'s former company names?

Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.

What is the Commission File Number for Cocrystal Pharma, Inc.?

The Commission File Number for Cocrystal Pharma, Inc. is 001-38418.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding Cocrystal Pharma, Inc. (COCP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing